Recommandation pour la prise en charge d'une RTU
Traitement de la maladie de Takayasu répondant aux critères d’Ishikawa et résistant aux traitements conventionnels (corticoïdes et immunosuppresseurs
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
p8qE36FCmMZqtzCs
Listen
